Niki BioSolutions, Inc.: 20-F filed 2022-04-29

Name: Niki BioSolutions, Inc.: 20-F filed 2022-04-29
Creator: Niki BioSolutions, Inc.

What Niki BioSolutions, Inc. reported in its annual report (foreign private issuer) filed 2022-04-29 (fiscal FY 2021): 44 published measures, 114 facts as tagged in accession 0001213900-22-022702.

This filing

Form: 20-F (annual report (foreign private issuer))
Filed: 2022-04-29
Fiscal period: fiscal FY 2021
Accession: 0001213900-22-022702 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Niki BioSolutions, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2021-12-31	21,907,243	USD
At 2020-12-31	44,231,316	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2021-12-31	4,401,121	USD
At 2020-12-31	6,079,023	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2021-12-31	23,607,345	USD
At 2020-12-31	41,834,151	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2021-01-01 to 2021-12-31	-27,114,293	USD	365
2020-01-01 to 2020-12-31	4,920,167	USD	366
2019-01-01 to 2019-12-31	-20,116,938	USD	365

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2021-01-01 to 2021-12-31	-14,651,633	USD	365
2020-01-01 to 2020-12-31	-15,931,913	USD	366
2019-01-01 to 2019-12-31	-13,382,633	USD	365

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2021-01-01 to 2021-12-31	131,750	USD	365
2020-01-01 to 2020-12-31	161,314	USD	366
2019-01-01 to 2019-12-31	837,062	USD	365

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2021-01-01 to 2021-12-31	2,780,725	USD	365
2020-01-01 to 2020-12-31	12,421,932	USD	366
2019-01-01 to 2019-12-31	-7,323,371	USD	365

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2021-01-01 to 2021-12-31	16,507,039	USD	365
2020-01-01 to 2020-12-31	1,842,164	USD	366
2019-01-01 to 2019-12-31	-108,061	USD	365

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2021-12-31	-55,537,515	USD
At 2020-12-31	-30,489,126	USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

Period	Value	Unit	Days
2021-01-01 to 2021-12-31	35,033,970	shares	365
2020-01-01 to 2020-12-31	31,135,882	shares	366
2019-01-01 to 2019-12-31	29,008,445	shares	365

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

Period	Value	Unit	Days
2021-01-01 to 2021-12-31	35,033,970	shares	365
2020-01-01 to 2020-12-31	31,534,473	shares	366
2019-01-01 to 2019-12-31	29,008,445	shares	365

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

Period	Value	Unit	Days
2021-01-01 to 2021-12-31	-0.71	USD/shares	365
2020-01-01 to 2020-12-31	0.2	USD/shares	366
2019-01-01 to 2019-12-31	-0.64	USD/shares	365

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

Period	Value	Unit	Days
2021-01-01 to 2021-12-31	-0.71	USD/shares	365
2020-01-01 to 2020-12-31	0.2	USD/shares	366
2019-01-01 to 2019-12-31	-0.64	USD/shares	365

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2021-12-31	3,731,116	USD
At 2020-12-31	4,686,323	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2021-01-01 to 2021-12-31	1,682,460	USD	365
2020-01-01 to 2020-12-31	1,478,565	USD	366
2019-01-01 to 2019-12-31	1,612,832	USD	365

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2021-12-31	12,688,300	USD
At 2020-12-31	33,656,815	USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2021-12-31	4,377,268	USD
At 2020-12-31	3,868,694	USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

Period	Value	Unit	Days
At 2021-12-31	880,256	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2021-12-31	78,722	USD
At 2020-12-31	62,221	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2021-01-01 to 2021-12-31	20,749,213	USD	365
2020-01-01 to 2020-12-31	21,187,050	USD	366
2019-01-01 to 2019-12-31	18,733,617	USD	365

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

Period	Value	Unit	Days
At 2021-12-31	35,775	USD
At 2020-12-31	39,133	USD

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2021-01-01 to 2021-12-31	10,869,642	USD	365
2020-01-01 to 2020-12-31	11,586,923	USD	366
2019-01-01 to 2019-12-31	6,939,051	USD	365

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

Period	Value	Unit
At 2021-12-31	8,261,487	USD
At 2020-12-31	3,625,356	USD
At 2019-12-31	5,293,173	USD
At 2018-12-31	26,107,238	USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2021-12-31	43,506,717	USD
At 2020-12-31	38,247,903	USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

Period	Value	Unit	Days
At 2021-12-31	-2,019	USD
At 2020-12-31	53,296	USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

Period	Value	Unit
At 2021-12-31	17,506,122	USD
At 2020-12-31	38,152,293	USD
At 2019-12-31	14,851,752	USD
At 2018-12-31	32,745,902	USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

Period	Value	Unit	Days
At 2021-12-31	154,439	USD
At 2020-12-31	547,389	USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

Period	Value	Unit	Days
At 2021-12-31	169,244	USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

Period	Value	Unit	Days
At 2021-12-31	7,209,458	USD
At 2020-12-31	7,079,589	USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Period	Value	Unit	Days
At 2021-12-31	3,478,342	USD
At 2020-12-31	2,393,266	USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

Period	Value	Unit	Days
At 2021-12-31	880,256	USD
At 2020-12-31	964,857	USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

Period	Value	Unit	Days
At 2021-12-31	593,478	USD
At 2020-12-31	1,378,996	USD

Net deferred tax assets

Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.

Period	Value	Unit
At 2021-12-31	12,632,164	USD
At 2020-12-31	9,561,560	USD
At 2019-12-31	6,152,198	USD
At 2018-12-31	3,054,000	USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

Period	Value	Unit	Days
2021-01-01 to 2021-12-31	-27,114,293	USD	365
2020-01-01 to 2020-12-31	4,920,167	USD	366
2019-01-01 to 2019-12-31	-20,116,938	USD	365

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

Period	Value	Unit	Days
2021-01-01 to 2021-12-31	-25,103,704	USD	365
2020-01-01 to 2020-12-31	6,370,188	USD	366
2019-01-01 to 2019-12-31	-18,697,659	USD	365

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

Period	Value	Unit	Days
2021-01-01 to 2021-12-31	-25,048,389	USD	365
2020-01-01 to 2020-12-31	6,311,340	USD	366
2019-01-01 to 2019-12-31	-18,686,762	USD	365

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2021-01-01 to 2021-12-31	5,409,302	USD	365
2020-01-01 to 2020-12-31	4,853,488	USD	366
2019-01-01 to 2019-12-31	7,373,425	USD	365

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

Period	Value	Unit	Days
2021-01-01 to 2021-12-31	1,086,564	USD	365
2020-01-01 to 2020-12-31	1,128,867	USD	366
2019-01-01 to 2019-12-31	1,071,799	USD	365

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

Period	Value	Unit	Days
2021-01-01 to 2021-12-31	1,192,578	USD	365
2020-01-01 to 2020-12-31	1,334,661	USD	366
2019-01-01 to 2019-12-31	1,299,618	USD	365

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2021-01-01 to 2021-12-31	-7,906,858	USD	365
2020-01-01 to 2020-12-31	25,195,708	USD	366
2019-01-01 to 2019-12-31	-1,918,487	USD	365

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

Period	Value	Unit	Days
2021-01-01 to 2021-12-31	273,155	USD	365
2020-01-01 to 2020-12-31	131,554	USD	366
2019-01-01 to 2019-12-31	557,333	USD	365

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

Period	Value	Unit	Days
2021-01-01 to 2021-12-31	4,000,000	USD	365
2020-01-01 to 2020-12-31	17,497,426	USD	366

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2021-01-01 to 2021-12-31	16,501	USD	365
2020-01-01 to 2020-12-31	21,678	USD	366
2019-01-01 to 2019-12-31	37,716	USD	365

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

Period	Value	Unit	Days
2021-01-01 to 2021-12-31	-3,358	USD	365
2020-01-01 to 2020-12-31	4,948	USD	366
2019-01-01 to 2019-12-31	3,543	USD	365

Inspect the source

Entity: Niki BioSolutions, Inc. / CIK 0001734005
Captured: 2026-09-21T17:25:26.957Z
SEC response SHA-256: f34238bceb73cca1adaefab8f58fd2e934415f294cf76da9d5479015a6447310

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001734005.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))